INTRODUCTION AND OBJECTIVES:
The most devastating complication following penile prosthesis (PP) implantation is an infection requiring device explantation. Current AUA guidelines recommend antibiotic prophylaxis before PPI with an aminoglycoside and either a 1st/2nd generation cephalosporin or vancomycin. We conducted a multi-institutional study to examine infection rates in diabetic patients undergoing PP implantation with different prophylactic antibiotic regimens, and compared outcomes based on adherence to AUA guidelines.
METHODS: Between April 2003 and May 2018, data was collected from 15 different institutions, and charts of 710 patients with diabetes receiving primary PP implantation were reviewed. Demographic data including age, race, Body Mass Index (BMI), and type of diabetes were collected for each patient. Pre-operative antibiotic regimen was recorded for each patient and primary outcomes were post-operative infection, explantation, and revision rates. Patients were included in the analysis only if they had complete information regarding perioperative antibiotics and outcomes. Univariate comparisons of proportions were completed for rates of infection, explantation, and revision between different antibiotic regimens. RESULTS: Overall, 603 patients had complete records and were included in this study. Median follow up was 7 months (range: 0 -157). The total number of infections, explantations, and revisions for all patients included were 23 (3.8%), 29 (4.8%), and 33 (5.5%), respectively. The AUA prophylaxis guidelines were followed in 282 patients, 220 (36.5%) received Gentamicin þ Vancomycin as prophylaxis and 62 (10.3%) received Gentamicin þ Cephalosporin (Cefazolin), while 321 (53.2%) received prophylaxis that differed from guidelines. The number of infections in the AUA guidelines group was 17 (6.0%) vs. 6 (1.9%) for the non-AUA guidelines group, p [ 0.008. The number of explantations in the AUA guidelines group was 23 (8.2%) vs. 6 (1.9%) in the non-AUA guidelines group, p < 0.001. There was no significant difference in revision rates between the two groups (p [ 0.360). On further analysis, the infection rate for patients treated with Gentamicin þ Vancomycin (7.73%) dropped significantly when a Quinolone (1.04%) was added to the regimen, p[0.001. Similar reductions were seen with explantation (9.6% to 1.0%, p < 0.001) and revision (8.2% to 3.1%, p [ 0.028) rates. Adding an anti-fungal in combination with Gentamicin þ Vancomycin non-significantly lowered the infection (0%), explantation (2.9%), and revision (0%) rates.
CONCLUSIONS: Adherence to the AUA penile prosthesis antibiotic prophylaxis guidelines confers a higher rate of device infection in diabetic patients. A high rate of infection was noted in patients receiving the most commonly prescribed antibiotic regimen of Gentamicin þ Vancomycin. The AUA guidelines should be amended to reflect findings of this and other device infection related studies.
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PD44-10 SEXUAL FUNCTION AFTER PENILE INVERSION VAGINOPLASTY
Virginia Li*, Amanda Chi, Melissa Poh, Polina Reyblat, Los Angeles, CA INTRODUCTION AND OBJECTIVES: Gender dysphoria affects 0.6% of adults in the United States (US). Gender affirmation surgery (GAS) helps patients align their genitalia with their gender identity. Historically, access to surgery was scattered and limited in the US, which impeded long term follow-up of patient's sexual function. We report sexual function outcomes of the first 50 penile inversion vaginoplasties done at a single institution.
METHODS: All patients who underwent a penile inversion vaginoplasty at Kaiser Permanente Southern California 2017-2018 were included. Patients satisfied criteria for GAS per World Professional Association for Transgender Health (WPATH) guidelines. Preoperative data includes age, genitourinary exam, sexual preference, length of hormone therapy, and medical comorbidities. Postoperatively, clitoral sensation, vaginal sensation, sexual satisfaction/ability to orgasm, and satisfaction with genital appearance were recorded.
RESULTS: The first 50 consecutive vaginoplasties were reviewed. All patients were followed for a minimal of 6 months with 100% patient follow-up (range 6-24 months). Mean age was 44 (range 18-74). All patients reported erogenous clitoral sensation (100%), and interested patients have reported ability to participate in satisfactory vaginal penetrative intercourse. Additionally, 24% reported orgasm with vaginal intercourse. 20% of patients underwent minor revision procedures (labiaplasty/clitoroplasty/urethroplasty) to improve cosmetic appearance and/or direction of urine flow. Overall satisfaction has been high with no regret from our patient population. CONCLUSIONS: GAS within an integrated system allows comprehensive long-term follow-up of patients. Single stage vaginoplasty in our first 50 patients has excellent outcomes. It results in functional vagina, sensate clitoris, cosmetically appropriate external genitalia and preservation of urinary function. Minor revisions were only needed in 20% of patients. Overall satisfaction with penile inversion vaginoplasty is high in terms of sexual functionality, genital appearance, and ability to achieve orgasm.
